Magnitude of Rotavirus A and Campylobacter jejuni infections in children with diarrhea in Twin cities of Rawalpindi and Islamabad, Pakistan.
Coinfection
disease burden
gastroenteritis
morbidity
mortality
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
21 Nov 2019
21 Nov 2019
Historique:
received:
15
05
2019
accepted:
16
10
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
29
1
2020
Statut:
epublish
Résumé
Acute diarrhea is a leading cause of morbidity and mortality in children particularly in developing countries of Asia and Africa. The present study was conducted to detect the two most important pathogens, rotavirus and Campylobacter Jejuni in children suffering with diarrhea in Rawalpindi and Islamabad, Pakistan in 2014. The clinical and epidemiological aspects of the disease were also investigated. A total of 500 stool samples were collected from children presented with clinical signs and symptoms of acute diarrhea. The samples were initially screened for the presence of rotavirus A (RVA) via ELISA (Enzyme-linked immunosorbent assay) and RT-PCR (Reverse Transcriptase PCR) and then were analysed for C. jejuni by using species specific PCR assay. The detection rate of RVA was 26.4% (132/500) while, Campylobacter was detected in 52% (260/500) of samples with C. jejuni accounted for 48.2% (241/500) of all study cases. Co-infection of C. jejuni with RVA was identified in 21.8% of all cases. Children with RVA and C. jejuni co-infection showed a higher probability (p = 0.01) to be dehydrated. A significant association (p = 0.02) was found between C. jejuni positive status and fever in children. The median age of children with both RVA and C. jejuni infection was 6-11 months. The RVA detection rate was high in winter months of the year while, C. jejuni infections were documented high in summer over 1 year study period. The overall results have demonstrated the high prevalence of C. jejuni in Rawalpindi, Islamabad, Pakistan in 2014. The results of present study will not only help to calculate disease burden caused by C. jejuni and rotavirus but also will provide critical information to health authorities in planning public health care strategies against these pathogens.
Sections du résumé
BACKGROUND
BACKGROUND
Acute diarrhea is a leading cause of morbidity and mortality in children particularly in developing countries of Asia and Africa. The present study was conducted to detect the two most important pathogens, rotavirus and Campylobacter Jejuni in children suffering with diarrhea in Rawalpindi and Islamabad, Pakistan in 2014. The clinical and epidemiological aspects of the disease were also investigated.
METHODS
METHODS
A total of 500 stool samples were collected from children presented with clinical signs and symptoms of acute diarrhea. The samples were initially screened for the presence of rotavirus A (RVA) via ELISA (Enzyme-linked immunosorbent assay) and RT-PCR (Reverse Transcriptase PCR) and then were analysed for C. jejuni by using species specific PCR assay.
RESULTS
RESULTS
The detection rate of RVA was 26.4% (132/500) while, Campylobacter was detected in 52% (260/500) of samples with C. jejuni accounted for 48.2% (241/500) of all study cases. Co-infection of C. jejuni with RVA was identified in 21.8% of all cases. Children with RVA and C. jejuni co-infection showed a higher probability (p = 0.01) to be dehydrated. A significant association (p = 0.02) was found between C. jejuni positive status and fever in children. The median age of children with both RVA and C. jejuni infection was 6-11 months. The RVA detection rate was high in winter months of the year while, C. jejuni infections were documented high in summer over 1 year study period.
CONCLUSIONS
CONCLUSIONS
The overall results have demonstrated the high prevalence of C. jejuni in Rawalpindi, Islamabad, Pakistan in 2014. The results of present study will not only help to calculate disease burden caused by C. jejuni and rotavirus but also will provide critical information to health authorities in planning public health care strategies against these pathogens.
Identifiants
pubmed: 31752744
doi: 10.1186/s12879-019-4575-1
pii: 10.1186/s12879-019-4575-1
pmc: PMC6868847
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
978Subventions
Organisme : HIGHER EDUCATION COMISSION OF PAKISTAN
ID : N/A
Références
Virol J. 2013 Oct 08;10:302
pubmed: 24099150
J Clin Diagn Res. 2014 May;8(5):PC01-5
pubmed: 24995223
Pol J Microbiol. 2017 Jan 2;65(4):433-442
pubmed: 28735327
Front Microbiol. 2018 Jan 26;9:52
pubmed: 29434579
Infect Genet Evol. 2013 Mar;14:161-8
pubmed: 23187023
PLoS One. 2018 Jun 28;13(6):e0199684
pubmed: 29953555
PLoS One. 2013;8(3):e59663
pubmed: 23555739
Epidemiol Infect. 2010 Sep;138(9):1215-26
pubmed: 20307341
Acta Trop. 2018 Sep;185:42-45
pubmed: 29709629
Diagn Microbiol Infect Dis. 2009 Jan;63(1):1-9
pubmed: 18990527
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
J Med Virol. 2012 Dec;84(12):2003-7
pubmed: 23080509
Glob Health Action. 2014 Feb 13;7:23695
pubmed: 24560268
J Pak Med Assoc. 2003 Nov;53(11):517-20
pubmed: 14738256
PLoS One. 2017 Sep 11;12(9):e0183392
pubmed: 28892480
Biotechnol Lett. 2006 Jan;28(1):55-9
pubmed: 16369876
PLoS One. 2019 Jul 30;14(7):e0220387
pubmed: 31361761
J Infect Dis. 2005 Sep 1;192 Suppl 1:S114-9
pubmed: 16088794
Vaccine. 2011 Jan 29;29(5):1053-71
pubmed: 21130754
BMC Pediatr. 2019 Jan 31;19(1):42
pubmed: 30704518
Kaohsiung J Med Sci. 2012 Nov;28(11):595-600
pubmed: 23140767
PLoS One. 2014 Oct 08;9(10):e108221
pubmed: 25295613
Asian Pac J Trop Med. 2015 Mar;8(3):197-202
pubmed: 25902160
Nat Rev Gastroenterol Hepatol. 2011 Oct 25;8(12):669-85
pubmed: 22025030
J Coll Physicians Surg Pak. 2014 Feb;24(2):114-7
pubmed: 24491006
Iran J Pediatr. 2012 Mar;22(1):63-9
pubmed: 23056861
Food Microbiol. 2007 May;24(3):219-22
pubmed: 17188200
J Infect Public Health. 2011 Mar;4(1):12-21
pubmed: 21338955
Am J Epidemiol. 2001 Jul 15;154(2):166-73
pubmed: 11447051
Pediatr Infect Dis J. 2017 Feb;36(2):168-172
pubmed: 27798545
Sci Rep. 2016 Jun 30;6:28737
pubmed: 27357336
Emerg Infect Dis. 2015 Apr;21(4):660-3
pubmed: 25811414
Lancet Glob Health. 2015 Sep;3(9):e564-75
pubmed: 26202075
J Clin Microbiol. 1992 Jun;30(6):1365-73
pubmed: 1320625
Jundishapur J Microbiol. 2014 Apr;7(4):e9148
pubmed: 25147694
Front Microbiol. 2019 May 03;10:940
pubmed: 31130934
J Clin Microbiol. 1990 Feb;28(2):276-82
pubmed: 2155916
Genome Biol Evol. 2015 Aug 08;7(9):2473-83
pubmed: 26254487
Eur J Epidemiol. 2004;19(9):877-83
pubmed: 15499898
Infect Genet Evol. 2017 Sep;53:160-166
pubmed: 28527973
PLoS Negl Trop Dis. 2013;7(1):e2036
pubmed: 23383356
Virusdisease. 2014;25(2):201-7
pubmed: 25674586
Am J Epidemiol. 2017 Nov 1;186(9):1074-1083
pubmed: 28541454
J Infect Dis. 2010 Sep 1;202 Suppl:S168-74
pubmed: 20684698
PLoS One. 2013 Jun 25;8(6):e67998
pubmed: 23825693
Emerg Infect Dis. 2002 Mar;8(3):237-44
pubmed: 11927019